March Altus Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
BIT
BFA
March Altus Capital Management's LLY Position: Q3 2016 in Review
March Altus Capital Management reduced its Eli Lilly (LLY) stake by 50% in Q3 2016, selling an estimated $1.08M and leaving 13,310 shares worth $1.07M. The position accounts for 6.68% of the portfolio, ranked #6.
March Altus Capital Management first reported a position in LLY in Q4 2013 and has held it in 12 quarters since. The position peaked at $19.3M in Q2 2014. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.
- March Altus Capital Management held 13,310 shares of Eli Lilly worth $1.07M as of Q3 2016.
- March Altus Capital Management sold 13,500 Eli Lilly shares in Q3 2016, an estimated $1.08M.
- Eli Lilly made up 6.68% of March Altus Capital Management's portfolio in Q3 2016, its #6 holding.
- March Altus Capital Management first reported a position in Eli Lilly in Q4 2013 and has held it in 12 quarters since.
- March Altus Capital Management's Eli Lilly position peaked at $19.3M in Q2 2014.
- 1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.
Based on March Altus Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.